Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 17 September 1999:
Vol. 285. no. 5435, pp. 1826 - 1827
DOI: 10.1126/science.285.5435.1826
Prev | Table of Contents | Next

News of the Week

BIOMEDICINE:
FDA Weighs Using Tumor Cell Lines for Vaccine Development

Gretchen Vogel

A technique for making vaccines that has been off limits in the United States for 40 years is now getting a second look from the U.S. Food and Drug Administration (FDA). Experts in cell biology, retrovirology, cancer, and vaccinology gathered in Rockville, Maryland, on 7 to 10 September to advise the FDA and other health agencies on the risks of using "immortal" and tumor-derived cells to generate viral particles for vaccines.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)